REVELATION BIOSCIENCES, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Revelation Biosciences, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2019 to Q2 2024.
  • Revelation Biosciences, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$8.39M, a 479% decline year-over-year.
  • Revelation Biosciences, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$15.9M, a 782% decline year-over-year.
  • Revelation Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$120K, a 98.9% increase from 2022.
  • Revelation Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.8M, a 9.66% increase from 2021.
  • Revelation Biosciences, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$12M, a 635% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 -$8.39M -$6.94M -479% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$2.68M -$8.84M -144% Mar 31, 2024 10-Q 2024-08-09
Q4 2023 -$2.2M -$995K -82.4% Dec 31, 2023 10-K 2024-03-22
Q3 2023 -$2.63M -$1.46M -125% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$1.45M +$387K +21.1% Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $6.16M +$12.8M Mar 31, 2023 10-Q 2024-08-09
Q4 2022 -$1.21M +$2.65M +68.7% Dec 31, 2022 10-K 2024-03-22
Q3 2022 -$1.17M +$1.87M +61.5% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$1.83M +$635K +25.7% Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$6.62M -$4M -153% Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$3.86M -$2.24M -138% Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$3.04M -$3.04M Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$2.47M -$2.47M Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$2.61M -$2.61M -36385% Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$1.62M -$1.62M Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$868* Sep 30, 2020 10-Q 2021-10-29
Q2 2020 -$521* Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$7.16K Mar 31, 2020 10-Q 2021-06-22
Q4 2019 -$3.64K* Dec 31, 2019 10-K/A 2021-06-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.